Exchange Traded Concepts LLC increased its stake in shares of Novanta Inc. (NASDAQ:NOVT – Free Report) by 12.1% in the fourth quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 199,964 shares of the technology company’s stock after purchasing an additional 21,589 shares during the period. Exchange Traded Concepts LLC owned approximately 0.56% of Novanta worth $23,794,000 as of its most recent SEC filing.
Other institutional investors and hedge funds have also added to or reduced their stakes in the company. Vanguard Group Inc. boosted its holdings in Novanta by 4.6% during the third quarter. Vanguard Group Inc. now owns 4,378,888 shares of the technology company’s stock worth $438,546,000 after buying an additional 193,366 shares during the last quarter. Wasatch Advisors LP grew its position in shares of Novanta by 10.6% during the 2nd quarter. Wasatch Advisors LP now owns 1,100,029 shares of the technology company’s stock worth $141,827,000 after buying an additional 104,985 shares during the period. JPMorgan Chase & Co. increased its stake in shares of Novanta by 4.2% in the 3rd quarter. JPMorgan Chase & Co. now owns 753,111 shares of the technology company’s stock valued at $75,424,000 after acquiring an additional 30,674 shares during the last quarter. Bamco Inc. NY increased its stake in shares of Novanta by 101.6% in the 3rd quarter. Bamco Inc. NY now owns 627,093 shares of the technology company’s stock valued at $62,803,000 after acquiring an additional 315,978 shares during the last quarter. Finally, Congress Asset Management Co. raised its position in shares of Novanta by 3.6% in the 4th quarter. Congress Asset Management Co. now owns 611,978 shares of the technology company’s stock valued at $72,819,000 after acquiring an additional 21,331 shares during the period. Institutional investors own 98.35% of the company’s stock.
Novanta Trading Down 4.5%
NASDAQ:NOVT opened at $113.15 on Friday. The company has a debt-to-equity ratio of 0.16, a current ratio of 3.69 and a quick ratio of 2.80. The business’s 50-day simple moving average is $133.23 and its 200-day simple moving average is $121.27. Novanta Inc. has a fifty-two week low of $98.27 and a fifty-two week high of $149.95. The stock has a market capitalization of $4.04 billion, a PE ratio of 77.50 and a beta of 1.61.
Analyst Ratings Changes
A number of brokerages recently issued reports on NOVT. Zacks Research upgraded shares of Novanta from a “strong sell” rating to a “hold” rating in a report on Friday, January 16th. Weiss Ratings upgraded shares of Novanta from a “sell (d+)” rating to a “hold (c-)” rating in a report on Tuesday, January 20th. Finally, Robert W. Baird set a $150.00 price target on shares of Novanta in a research report on Wednesday, February 25th. Three equities research analysts have rated the stock with a Hold rating, According to data from MarketBeat.com, the stock has a consensus rating of “Hold” and a consensus target price of $150.00.
Check Out Our Latest Stock Report on NOVT
Insider Buying and Selling at Novanta
In related news, CEO Matthijs Glastra sold 7,500 shares of the firm’s stock in a transaction on Tuesday, February 10th. The shares were sold at an average price of $145.04, for a total transaction of $1,087,800.00. Following the sale, the chief executive officer directly owned 57,367 shares in the company, valued at $8,320,509.68. This trade represents a 11.56% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. Also, CFO Robert Buckley sold 9,957 shares of the business’s stock in a transaction on Monday, March 16th. The shares were sold at an average price of $116.77, for a total transaction of $1,162,678.89. Following the completion of the sale, the chief financial officer directly owned 96,616 shares in the company, valued at $11,281,850.32. This represents a 9.34% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold 34,303 shares of company stock valued at $4,545,416 in the last three months. 1.20% of the stock is owned by insiders.
Novanta Profile
Novanta, Inc (NASDAQ: NOVT) is a global technology company that designs and manufactures precision components, subsystems and software used in advanced photonics and motion control applications. The company serves customers in the medical device and advanced industrial markets, supplying critical technologies for diagnostics and therapeutic systems, semiconductor and electronics manufacturing, and scientific instrumentation. Novanta’s product portfolio includes laser control modules, optics, beam delivery systems, high-precision motors, actuators, stages, and fluidics solutions designed to meet stringent accuracy and reliability requirements.
Novanta’s Photonics segment delivers laser and energy delivery components that enable minimally invasive surgical procedures and diagnostic imaging.
Further Reading
Want to see what other hedge funds are holding NOVT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Novanta Inc. (NASDAQ:NOVT – Free Report).
Receive News & Ratings for Novanta Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Novanta and related companies with MarketBeat.com's FREE daily email newsletter.
